MedTrace Logo

Methotrexat to Hand Eczema in the BIOSKIN Cohort

NCT07338305 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-01-13

No results posted yet for this study

Summary

Handeczema is a common chronic skin disease that markedly affect health and quality of life. Effective treatment is limited by the lack of biomarkers that can predict disease course, comorbidities and treatment response. This study is is an observational, prospective, study of patients initiating treatment with methotrexat at the Department of Dermatology and Allergy at Herlev- and Gentofte Hospital.

The main aim is to study the clinical effect of methotrexat in patients with hand eczema. Secondary aims are to study drug survival, reasons for termination of treatment and side effects.

Conditions

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • Lone Skov

    lead OTHER

Principal Investigators

  • Lone Skov, Professor · Department of Dermatology and Allergy, Herlev and Gentofte Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07338305 on ClinicalTrials.gov